Key result
Apolipoprotein L1 risk variants may cause kidney cell toxicity through a peroxisomal pathway of injury specifically activated under hypoxic conditions.
Answers are grounded in this paper and cite their sources.
The commentary highlights a novel proposed mechanism involving a peroxisomal pathway under hypoxia for APOL1-mediated kidney injury.
Apolipoprotein L1 risk variants contribute to high rates of kidney disease among individuals of African ancestry. These gain-of-function variants cause toxicity to kidney cells, but the mechanism of injury is not clear. Many theories have been proposed, yet the field has not arrived at a consensus. Kim et al. make a compelling argument for a peroxisomal pathway of injury specifically activated under hypoxic conditions. Introducing cellular context reframes the debate about apolipoprotein L1 mechanism of disease.
No takes yet. Share an insight, caveat, or question.
Friedman et al. (2026) conducted an editorial in APOL1 kidney disease. Apolipoprotein L1 risk variants was evaluated. Apolipoprotein L1 risk variants may cause kidney cell toxicity through a peroxisomal pathway of injury specifically activated under hypoxic conditions.
Synapse has enriched 10 related papers. Consider them for comparative context: